Basic Information
GuideTx focuses on the development of non-viral delivery vectors for gene therapy. The company aims to use CRISPR-based base editing technology to precisely modify single bases in the genome, thereby treating genetic diseases caused by single-point mutations in genes.
Guide Therapeutics, Inc.
Atlanta,Georgia,United States of America
15~50 people
January 01, 2017
contact@guidetx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios